NYSE:CLBCore Laboratories Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Core Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $20.22 +0.25 (+1.25 %) (As of 06/1/2020 04:00 PM ET) Add Compare Share Today's Range$18.85Now: $20.22▼$20.3850-Day Range$10.81MA: $16.76▼$20.5952-Week Range$6.68Now: $20.22▼$56.03Volume1.19 million shsAverage Volume1.47 million shsMarket Capitalization$898.92 millionP/E RatioN/ADividend Yield0.20%Beta3.05 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.Read More Beat the Market (BTM) Rank™ 4.1 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 3 buy ratings, 11 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $30.93, Core Laboratories has a potential upside of 52.9% from its current price of $20.22.Amount of Analyst CoverageCore Laboratories has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.1 Community Rank Outperform VotesCore Laboratories has received 465 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCore Laboratories has received 625 “underperform” votes. (Add your “underperform” vote.)Community SentimentCore Laboratories has received 57.34% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote “Outperform” if you believe CLB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 3.3 Dividend Strength Dividend LeadershipCore Laboratories is a leading dividend payer. It pays a dividend yield of 0.20%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 2.23 %. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 8.00 % next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,242.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.11% of the stock of Core Laboratories is held by insiders. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to decrease by -27.54% in the coming year, from $0.69 to $0.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is -18.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is -18.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 28.94. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 4.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.1Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.50 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB Previous Symbol CUSIPN/A CIK1000229 Webwww.corelab.com Phone31-20-420-3191Debt Debt-to-Equity Ratio5.17 Current Ratio2.03 Quick Ratio1.54Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio29.30 P/E Growth28.94 Sales & Book Value Annual Sales$668.21 million Price / Sales1.35 Cash Flow$2.31 per share Price / Cash Flow8.76 Book Value$4.10 per share Price / Book4.93Profitability EPS (Most Recent Fiscal Year)$1.79 Net Income$101.98 million Net Margins-7.21% Return on Equity46.28% Return on Assets9.89%Miscellaneous Employees4,300 Outstanding Shares44,457,000Market Cap$898.92 million Next Earnings Date7/22/2020 (Estimated) OptionableOptionable CLB Rates by TradingView Receive CLB News and Ratings via Email Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Core Laboratories (NYSE:CLB) Frequently Asked Questions How has Core Laboratories' stock been impacted by COVID-19 (Coronavirus)? Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 85.0% and is now trading at $20.22. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Core Laboratories? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Core Laboratories. When is Core Laboratories' next earnings date? Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Core Laboratories. How were Core Laboratories' earnings last quarter? Core Laboratories (NYSE:CLB) issued its earnings results on Wednesday, April, 22nd. The oil and gas company reported $0.31 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.33 by $0.02. The oil and gas company earned $152.40 million during the quarter, compared to analyst estimates of $151.37 million. Core Laboratories had a negative net margin of 7.21% and a positive return on equity of 46.28%. Core Laboratories's revenue for the quarter was down 9.9% on a year-over-year basis. During the same quarter last year, the company earned $0.44 EPS. View Core Laboratories' earnings history. How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories declared a quarterly dividend on Tuesday, April 28th. Stockholders of record on Friday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 19th. This represents a $0.04 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date is Thursday, May 7th. View Core Laboratories' dividend history. What price target have analysts set for CLB? 15 equities research analysts have issued 12 month price objectives for Core Laboratories' shares. Their forecasts range from $7.50 to $77.00. On average, they anticipate Core Laboratories' share price to reach $30.93 in the next year. This suggests a possible upside of 52.9% from the stock's current price. View analysts' price targets for Core Laboratories. Has Core Laboratories been receiving favorable news coverage? Media headlines about CLB stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Core Laboratories earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned media stories about the oil and gas company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutCore Laboratories. Are investors shorting Core Laboratories? Core Laboratories saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,500,000 shares, an increase of 5.3% from the April 30th total of 6,170,000 shares. Based on an average daily trading volume, of 1,890,000 shares, the short-interest ratio is currently 3.4 days. Currently, 14.8% of the company's stock are short sold. View Core Laboratories' Current Options Chain. Who are some of Core Laboratories' key competitors? Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), SemGroup (SEMG), RPC (RES), Oceaneering International (OII), NexTier Oilfield Solutions (NEX), Select Energy Services (WTTR), Liberty Oilfield Services (LBRT), Franks International (FI), Helix Energy Solutions Group (HLX), Propetro (PUMP), National Energy Services Reunited (NESR), Keane Group (FRAC), North American Construction Group (NOA), Hurricane Energy (HRCXF) and Key Energy Services (KEGX). View all competitors. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Starbucks (SBUX), Micron Technology (MU), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T) and Baidu (BIDU). Who are Core Laboratories' key executives? Core Laboratories' management team includes the following people: Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Van ECK Associates Corp (12.38%), Massachusetts Financial Services Co. MA (7.53%), BlackRock Inc. (6.65%), Clearbridge Investments LLC (4.11%), Bank of New York Mellon Corp (3.06%) and Deutsche Bank AG (2.21%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View institutional ownership trends for Core Laboratories. Which institutional investors are selling Core Laboratories stock? CLB stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Nuveen Asset Management LLC, Wells Fargo & Company MN, Principal Financial Group Inc., BlackRock Inc., Baird Financial Group Inc., and Mcdonald Capital Investors Inc. CA. View insider buying and selling activity for Core Laboratories. Which institutional investors are buying Core Laboratories stock? CLB stock was purchased by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Deutsche Bank AG, Luminus Management LLC, Bank of New York Mellon Corp, C Partners Holding GmbH, Morgan Stanley, Morgan Stanley, and Two Sigma Advisers LP. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno. View insider buying and selling activity for Core Laboratories. How do I buy shares of Core Laboratories? Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $20.22. How big of a company is Core Laboratories? Core Laboratories has a market capitalization of $898.92 million and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe. What is Core Laboratories' official website? The official website for Core Laboratories is www.corelab.com. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected] This page was last updated on 6/1/2020 by MarketBeat.com Staff
